9GEJ
 
 | Crystal structure of CREBBP bromodomain in complex with (2R,13S,E)-2-methyl-1,2,3,5,10,11,13,14,20,21,24,25-dodecahydro-19H,23H-16,18-etheno-9,13-methano-7,28-(metheno)[1,4]diazepino[2,3-k]pyrido[1,2-s][1,4]dioxa[7,19]diazacyclodocosine-4,8-dione | Descriptor: | 2R,13S,E)-2-methyl-1,2,3,5,10,11,13,14,20,21,24,25-dodecahydro-19H,23H-16,18-etheno-9,13-methano-7,28-(metheno)[1,4]diazepino[2,3-k]pyrido[1,2-s][1,4]dioxa[7,19]diazacyclodocosine-4,8-dione, CREBBP, SULFATE ION | Authors: | Amann, M, Boyd, A, Einsle, O, Guenther, S, Moroglu, M, Conway, S. | Deposit date: | 2024-08-07 | Release date: | 2025-08-20 | Method: | X-RAY DIFFRACTION (1.84 Å) | Cite: | Crystal structure of CREBBP bromodomain in complex with (2R,13S,E)-2-methyl-1,2,3,5,10,11,13,14,20,21,24,25-dodecahydro-19H,23H-16,18-etheno-9,13-methano-7,28-(metheno)[1,4]diazepino[2,3-k]pyrido[1,2-s][1,4]dioxa[7,19]diazacyclodocosine-4,8-dione To Be Published
|
|
9GEL
 
 | |
9GES
 
 | |
9GET
 
 | Crystal structure of CREBBP bromodomain in complex with (R,E)-6-(5-(7-methoxy-3,4-dihydroquinolin-1(2H)-yl)pent-1-en-1-yl)-4-methyl-8-(morpholine-4-carbonyl)-1,3,4,5-tetrahydro-2H-benzo[b][1,4]diazepin-2-one | Descriptor: | (4~{R})-6-[(~{E})-5-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)pent-1-enyl]-4-methyl-8-morpholin-4-ylcarbonyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one, CREBBP | Authors: | Amann, M, Boyd, A, Einsle, O, Guenther, S, Monoglu, M, Conway, S. | Deposit date: | 2024-08-07 | Release date: | 2025-08-20 | Method: | X-RAY DIFFRACTION (1.29 Å) | Cite: | Crystal structure of CREBBP bromodomain in complex with (R,E)-6-(5-(7-methoxy-3,4-dihydroquinolin-1(2H)-yl)pent-1-en-1-yl)-4-methyl-8-(morpholine-4-carbonyl)-1,3,4,5-tetrahydro-2H-benzo[b][1,4]diazepin-2-one To Be Published
|
|
9GEU
 
 | Crystal structure of CREBBP bromodomain in complex with (R,E)-2-methyl-1,2,3,5,10,11,17,18,21,22-decahydro-4H,16H,20H-13,15-etheno-7,25-(metheno)[1,4]diazepino[2,3-h]pyrido[1,2-p][1]oxa[4,16]diazacyclononadecine-4,8(9H)-dione | Descriptor: | (R,E)-2-methyl-1,2,3,5,10,11,17,18,21,22-decahydro-4H,16H,20H-13,15-etheno-7,25-(metheno)[1,4]diazepino[2,3-h]pyrido[1,2-p][1]oxa[4,16]diazacyclononadecine-4,8(9H)-dione, (R,R)-2,3-BUTANEDIOL, CITRIC ACID, ... | Authors: | Amann, M, Boyd, A, Einsle, O, Guenther, S, Moroglu, M, Conway, S. | Deposit date: | 2024-08-07 | Release date: | 2025-08-20 | Method: | X-RAY DIFFRACTION (1.56 Å) | Cite: | Crystal structure of the human CREBBP bromodomain in complex with (R,E)-2-methyl-1,2,3,5,10,11,17,18,21,22-decahydro-4H,16H,20H-13,15-etheno-7,25-(metheno)[1,4]diazepino[2,3-h]pyrido[1,2-p][1]oxa[4,16]diazacyclononadecine-4,8(9H)-dione To Be Published
|
|
9GEV
 
 | |
9GEW
 
 | Crystal structure of CREBBP bromodomain in complex with (R,E)-6-(5-(6-methoxy-2,3-dihydro-4H-benzo[b][1,4]oxazin-4-yl)pent-1-en-1-yl)-4-methyl-1,3,4,5-tetrahydro-2H-benzo[b][1,4]diazepin-2-one | Descriptor: | (4~{R})-6-[(~{E})-5-(6-methoxy-2,3-dihydro-1,4-benzoxazin-4-yl)pent-1-enyl]-4-methyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one, (R,R)-2,3-BUTANEDIOL, CREBBP | Authors: | Amann, M, Boyd, A, Einsle, O, Moroglu, M, Conway, S. | Deposit date: | 2024-08-07 | Release date: | 2025-08-20 | Method: | X-RAY DIFFRACTION (1.47 Å) | Cite: | Crystal structure of CREBBP bromodomain in complex with (R,E)-6-(5-(6-methoxy-2,3-dihydro-4H-benzo[b][1,4]oxazin-4-yl)pent-1-en-1-yl)-4-methyl-1,3,4,5-tetrahydro-2H-benzo[b][1,4]diazepin-2-one To Be Published
|
|
9GEY
 
 | Crystal structure of CREBBP bromodomain in complex with (R,E)-2-methyl-1,2,3,5,9,10,11,12,18,19,22,23-dodecahydro-17H,21H-14,16-etheno-7,26-(metheno)[1,4]diazepino[2,3-l]pyrido[2,1-d][1]oxa[5,17]diazacycloicosine-4,8-dione | Descriptor: | (R,E)-2-methyl-1,2,3,5,9,10,11,12,18,19,22,23-dodecahydro-17H,21H-14,16-etheno-7,26-(metheno)[1,4]diazepino[2,3-l]pyrido[2,1-d][1]oxa[5,17]diazacycloicosine-4,8-dione, 1,2-ETHANEDIOL, CREBBP | Authors: | Amann, M, Boyd, A, Einsle, O, Guenther, S, Moroglu, M, Conway, S. | Deposit date: | 2024-08-07 | Release date: | 2025-08-20 | Method: | X-RAY DIFFRACTION (1.56 Å) | Cite: | Crystal structure of CREBBP bromodomain in complex with (R,E)-2-methyl-1,2,3,5,9,10,11,12,18,19,22,23-dodecahydro-17H,21H-14,16-etheno-7,26-(metheno)[1,4]diazepino[2,3-l]pyrido[2,1-d][1]oxa[5,17]diazacycloicosine-4,8-dione To Be Published
|
|
9GF1
 
 | Cysteine-less human Galectin-3 C173S mutant carbohydrate recognition domain | Descriptor: | CHLORIDE ION, GLYCEROL, Galectin-3, ... | Authors: | Blaha, J, Dubanych, Y, Skorepa, O, Vanek, O. | Deposit date: | 2024-08-08 | Release date: | 2025-08-20 | Method: | X-RAY DIFFRACTION (1.5 Å) | Cite: | Galectin-3 carbohydrate recognition is solely responsible for its binding to the NK cell activation receptor NKp30. To Be Published
|
|
9GF5
 
 | CRYSTAL STRUCTURE OF COMPLEX OF ASO BINDING FAB FRAGMENT IN COMPLEX WITH ASO980 | Descriptor: | 1,2-ETHANEDIOL, 1-[(2R,4S,5R)-4-[[(1R,3R,4R,7S)-7-[[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-[[(2R,3S,5R)-5-(4-azanyl-2-oxidanylidene-pyrimidin-1-yl)-3-oxidanyl-oxolan-2-yl]methoxy-sulfanyl-phosphoryl]oxy-oxolan-2-yl]methoxy-sulfanyl-phosphoryl]oxy-3-(4-azanyl-5-methyl-2-oxidanylidene-pyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-sulfanyl-phosphoryl]oxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione, 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID, ... | Authors: | Hung-En, H, Zanini, C, Simonneau, C, Fraidling, J, Kraft, T, Mayer, K, Sommer, A, Indlekofer, A, Wirth, T, Benz, J, Georges, G, Langer, M, Gassner, C, Larraillet, V, Manso, M, Ravn, J, Hofer, K, Emrich, T, Niewoehner, J, Schumacher, F, Brinkmann, U. | Deposit date: | 2024-08-08 | Release date: | 2025-08-20 | Method: | X-RAY DIFFRACTION (1.57 Å) | Cite: | Improved Targeted Delivery of Antisense Oligonucleotide Conjugates
with the Antibody Mask To Be Published
|
|
9GF6
 
 | |
9GFA
 
 | Crystal structure of 14-3-3 sigma in complex with Tau pS214 peptide and covalent stabilizer LD33 | Descriptor: | 14-3-3 protein sigma, 3-(3-bromanyl-4-methyl-phenyl)-2-pyridin-3-yl-1,2-dihydrobenzimidazole, Microtubule-associated protein tau | Authors: | van den Oetelaar, M.C.M, Engelen, S.F.H, Ottmann, C, Brunsveld, L. | Deposit date: | 2024-08-08 | Release date: | 2025-08-20 | Method: | X-RAY DIFFRACTION (1.6 Å) | Cite: | Site-selective stabilization of the 14-3-3/tau protein-protein interaction To Be Published
|
|
9GFB
 
 | |
9GFD
 
 | Crystal structure of ASO binding Fab fragment with ASO139 | Descriptor: | 1,2-ETHANEDIOL, 1-[(1~{S},3~{R},4~{R},7~{S})-7-[[(1~{R},3~{R},4~{R},7~{S})-7-[[(1~{R},3~{R},4~{R},7~{S})-3-(6-aminopurin-9-yl)-7-[[(2~{R},3~{S},5~{R})-5-(4-azanyl-2-oxidanylidene-pyrimidin-1-yl)-3-oxidanyl-oxolan-2-yl]methoxy-sulfanyl-phosphoryl]oxy-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-sulfanyl-phosphoryl]oxy-3-(4-azanyl-5-methyl-2-oxidanylidene-pyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-sulfanyl-phosphoryl]oxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-5-methyl-pyrimidine-2,4-dione, Fab Fragment light chain, ... | Authors: | Hsia, H.-E, Zanini, C, Simonneau, C, Fraidling, J, Kraft, T, Mayer, K, Sommer, A, Indlekofer, A, Wirth, T, Benz, J, Geroges, G, Langer, M.L, Gassner, C, Larraillet, V, Manso, M, Ravn, J, Hofer, K, Emrich, T, Niewoehner, J, Schumacher, F, Brinkmann, U. | Deposit date: | 2024-08-09 | Release date: | 2025-08-20 | Method: | X-RAY DIFFRACTION (1.43 Å) | Cite: | Improved Targeted Delivery of Antisense Oligonucleotide Conjugates
with the Antibody Mask To Be Published
|
|
9GFF
 
 | BCR Fab from the subset 1 chronic lymphocytic leukaemia case P10015 | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, BCR P10015 heavy chain, BCR P10015 light chain | Authors: | Minici, C, Degano, M. | Deposit date: | 2024-08-09 | Release date: | 2025-08-20 | Method: | X-RAY DIFFRACTION (2.8 Å) | Cite: | Defective cell-autonomous signalling and antigenic polyreactivity of B-cell receptors from chronic lymphocytic leukaemia stereotyped subset 1 To Be Published
|
|
9GFG
 
 | BCR Fab from the subset 1 chronic lymphocytic leukaemia case P3129 | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, BCR P3129 heavy chain, ... | Authors: | Minici, C, Degano, M. | Deposit date: | 2024-08-09 | Release date: | 2025-08-20 | Method: | X-RAY DIFFRACTION (2.3 Å) | Cite: | Defective cell-autonomous signalling and antigenic polyreactivity of B-cell receptors from chronic lymphocytic leukaemia stereotyped subset 1 To Be Published
|
|
9GFH
 
 | BCR Fab from the subset 1 chronic lymphocytic leukaemia case P1173 | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, BCR P1173 heavy chain, ... | Authors: | Cocomazzi, P.G, Degano, M. | Deposit date: | 2024-08-09 | Release date: | 2025-08-20 | Method: | X-RAY DIFFRACTION (2.72 Å) | Cite: | Defective cell-autonomous signalling and antigenic polyreactivity of B-cell receptors from chronic lymphocytic leukaemia stereotyped subset 1 To Be Published
|
|
9GFJ
 
 | Crystal structure of ASO binding Fab fragment with ASO143 | Descriptor: | 1,2-ETHANEDIOL, 1-[(1~{S},3~{R},4~{R},7~{S})-7-[[(1~{R},3~{R},4~{R},7~{S})-7-[[(1~{R},3~{R},4~{R},7~{S})-3-(6-aminopurin-9-yl)-7-[[(1~{R},3~{R},4~{R},7~{S})-3-(4-azanyl-5-methyl-2-oxidanylidene-pyrimidin-1-yl)-7-oxidanyl-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-sulfanyl-phosphoryl]oxy-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-sulfanyl-phosphoryl]oxy-3-(4-azanyl-5-methyl-2-oxidanylidene-pyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-sulfanyl-phosphoryl]oxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-5-methyl-pyrimidine-2,4-dione, 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID, ... | Authors: | Hsia, H.-E, Zanini, C, Simonneau, C, Fraidling, J, Kraft, T, Mayer, K, Sommer, A, Indlekofer, A, Wirht, T, Benz, J, Georges, G, Langer, L.M, Gassner, C, Larraillet, V, Manso, M, Ravn, J, Hofer, K, Emrich, T, Niewoehner, J, Schumacher, F, Brinkmann, U. | Deposit date: | 2024-08-09 | Release date: | 2025-08-20 | Method: | X-RAY DIFFRACTION (1.48 Å) | Cite: | Improved Targeted Delivery of Antisense Oligonucleotide Conjugates
with the Antibody Mask To Be Published
|
|
9GFL
 
 | Crystal structure of ASO binding Fab fragment | Descriptor: | 1,2-ETHANEDIOL, 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID, Fab fragment heavy chain, ... | Authors: | Hsia, H.-E, Zanini, C, Simonneau, C, Fraidling, J, Kraft, T, Mayer, K, Sommer, A, Indlekofer, A, Wirth, T, Benz, J, Georges, G, Langer, L.M, Gassner, C, Larraillet, V, Manso, M, Ravn, J, Hofer, K, Emrich, T, Niewoehner, J, Schumacher, F, Brinkmann, U. | Deposit date: | 2024-08-09 | Release date: | 2025-08-20 | Method: | X-RAY DIFFRACTION (1.68 Å) | Cite: | Improved Targeted Delivery of Antisense Oligonucleotide Conjugates
with the Antibody Mask To Be Published
|
|
9GFM
 
 | |
9GFP
 
 | The crystal structure of CsvR from Escherichia coli | Descriptor: | HTH-type transcriptional activator CsvR | Authors: | Moche, M, Joffre, E, Ampah-Korsah, H, Nyman, T, Sjoling, A, Sun, L. | Deposit date: | 2024-08-12 | Release date: | 2025-08-20 | Method: | X-RAY DIFFRACTION (3.03 Å) | Cite: | The crystal structure of CsvR from Escherichia coli To Be Published
|
|
9GFU
 
 | |
9GI1
 
 | Structure of the S.aureus MecA/ClpC/ClpP degradation system | Descriptor: | ADENOSINE-5'-DIPHOSPHATE, ATP-dependent Clp protease ATP-binding subunit ClpC, ATP-dependent Clp protease proteolytic subunit, ... | Authors: | Azinas, S, Wallden, K, Katikaridis, P, Schahl, A, Mogk, A, Carroni, M. | Deposit date: | 2024-08-16 | Release date: | 2025-08-20 | Method: | ELECTRON MICROSCOPY (3 Å) | Cite: | ClpC and ClpP act as reciprocal allosteric activators to form a highly efficient AAA+ protease To Be Published
|
|
9GOQ
 
 | |
9GTU
 
 | Collagen VI alpha 1, 2, 3 heterotrimer recombinant C terminal region. Local refinement. | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, Collagen alpha-1(VI) chain, ... | Authors: | Godwin, A, Snee, M, Dajani, R, Becker, M, Roseman, A, Baldock, C. | Deposit date: | 2024-09-18 | Release date: | 2025-08-20 | Method: | ELECTRON MICROSCOPY (3.14 Å) | Cite: | Collagen VI microfibril structure reveals mechanism for molecular assembly and clustering of inherited pathogenic mutations Nat Commun, 2025
|
|